Allarity Insider Buying Surge Signals Strong Confidence in Stenoparib Pipeline
Insider buying spurs confidence in Allarity Therapeutics as GMP‑compliant manufacturing of stenoparib and Phase II trials signal a bullish outlook for this high‑growth biotech.
4 minutes to read